195 related articles for article (PubMed ID: 15963201)
1. Assessment of efficacy and psychomotor performances of thiocolchicoside and tizanidine in patients with acute low back pain.
Ketenci A; Ozcan E; Karamursel S
Int J Clin Pract; 2005 Jul; 59(7):764-70. PubMed ID: 15963201
[TBL] [Abstract][Full Text] [Related]
2. Efficacy of thiocolchicoside in Indian patients suffering from low back pain associated with muscle spasm.
Soonawalla DF; Joshi N
J Indian Med Assoc; 2008 May; 106(5):331-5. PubMed ID: 18839644
[TBL] [Abstract][Full Text] [Related]
3. Efficacy and safety of eperisone in patients with low back pain: a double blind randomized study.
Cabitza P; Randelli P
Eur Rev Med Pharmacol Sci; 2008; 12(4):229-35. PubMed ID: 18727454
[TBL] [Abstract][Full Text] [Related]
4. To evaluate efficacy and safety of fixed dose combination of aceclofenac + paracetamol + thiocolchicoside (acenac-MR) in the treatment of acute low back pain.
Lahoti G
J Indian Med Assoc; 2012 Jan; 110(1):56-8. PubMed ID: 23029837
[TBL] [Abstract][Full Text] [Related]
5. Tizanidine treatment of spasticity caused by multiple sclerosis: results of a double-blind, placebo-controlled trial. US Tizanidine Study Group.
Smith C; Birnbaum G; Carter JL; Greenstein J; Lublin FD
Neurology; 1994 Nov; 44(11 Suppl 9):S34-42; discussion S42-3. PubMed ID: 7970009
[TBL] [Abstract][Full Text] [Related]
6. Nightly sublingual tizanidine HCl in multiple sclerosis: clinical efficacy and safety.
Vakhapova V; Auriel E; Karni A
Clin Neuropharmacol; 2010 May; 33(3):151-4. PubMed ID: 20502134
[TBL] [Abstract][Full Text] [Related]
7. A double-blind, placebo-controlled trial of tizanidine in the treatment of spasticity caused by multiple sclerosis. United Kingdom Tizanidine Trial Group.
Neurology; 1994 Nov; 44(11 Suppl 9):S70-8. PubMed ID: 7970014
[TBL] [Abstract][Full Text] [Related]
8. Clinical experience with eperisone in the treatment of acute low back pain.
Beltrame A; Grangiè S; Guerra L
Minerva Med; 2008 Aug; 99(4):347-52. PubMed ID: 18663343
[TBL] [Abstract][Full Text] [Related]
9. [The efficacy of sirdalud in the drug therapy of pain in the spine].
Iakhno NN; Damulin IV; Chernenko OA; Ianakaeva TA; Kondrat'eva ON; Kur'ianova PT
Ter Arkh; 1994; 66(10):10-2. PubMed ID: 7863433
[TBL] [Abstract][Full Text] [Related]
10. Efficacy and tolerability of paracetamol/tramadol (325 mg/37.5 mg) combination treatment compared with tramadol (50 mg) monotherapy in patients with subacute low back pain: a multicenter, randomized, double-blind, parallel-group, 10-day treatment study.
Perrot S; Krause D; Crozes P; Naïm C;
Clin Ther; 2006 Oct; 28(10):1592-606. PubMed ID: 17157115
[TBL] [Abstract][Full Text] [Related]
11. Summary of combined clinical analysis of controlled clinical trials with tizanidine.
Wallace JD
Neurology; 1994 Nov; 44(11 Suppl 9):S60-8; discussion S68-9. PubMed ID: 7970013
[TBL] [Abstract][Full Text] [Related]
12. Efficacy and safety of tizanidine in the treatment of spasticity in patients with spinal cord injury. North American Tizanidine Study Group.
Nance PW; Bugaresti J; Shellenberger K; Sheremata W; Martinez-Arizala A
Neurology; 1994 Nov; 44(11 Suppl 9):S44-51; discussion S51-2. PubMed ID: 7970010
[TBL] [Abstract][Full Text] [Related]
13. Eperisone versus tizanidine for treatment of chronic low back pain.
Rossi M; Ianigro G; Liberatoscioli G; Di Castelnuovo A; Grimani V; Garofano A; Camposarcone N; Nardi LF
Minerva Med; 2012 Jun; 103(3):143-9. PubMed ID: 22653094
[TBL] [Abstract][Full Text] [Related]
14. Multicenter, randomized, double-blinded, placebo-controlled trial of thiocolchicoside in acute low back pain.
Tüzün F; Unalan H; Oner N; Ozgüzel H; Kirazli Y; Içağasioğlu A; Kuran B; Tüzün S; Başar G
Joint Bone Spine; 2003 Sep; 70(5):356-61. PubMed ID: 14563464
[TBL] [Abstract][Full Text] [Related]
15. Open experience with a new myorelaxant agent for low back pain.
Sartini S; Guerra L
Adv Ther; 2008 Oct; 25(10):1010-8. PubMed ID: 18836866
[TBL] [Abstract][Full Text] [Related]
16. [The usefulness of tizanidine. A one-year follow-up of the treatment of spasticity in infantile cerebral palsy].
Vásquez-Briceño A; Arellano-Saldaña ME; León-Hernández SR; Morales-Osorio MG
Rev Neurol; 2006 Aug 1-15; 43(3):132-6. PubMed ID: 16871477
[TBL] [Abstract][Full Text] [Related]
17. Oxymorphone extended release for the treatment of chronic low back pain: a retrospective pooled analysis of enriched-enrollment clinical trial data stratified according to age, sex, and prior opioid use.
Peniston JH; Gould E
Clin Ther; 2009 Feb; 31(2):347-59. PubMed ID: 19302907
[TBL] [Abstract][Full Text] [Related]
18. Tizanidine for spasticity.
Med Lett Drugs Ther; 1997 Jul; 39(1004):62-3. PubMed ID: 9217694
[No Abstract] [Full Text] [Related]
19. Efficacy and safety of a fixed combination of intramuscular diclofenac 75 mg + thiocolchicoside 4 mg in the treatment of acute low back pain: a phase III, randomized, double blind, controlled trial.
Sproviero E; Albamonte E; Costantino C; Giossi A; Mancuso M; Rigamonti A; Tornari P; Caggiano G
Eur J Phys Rehabil Med; 2018 Oct; 54(5):654-662. PubMed ID: 29265793
[TBL] [Abstract][Full Text] [Related]
20. Low-dose cyclobenzaprine versus combination therapy with ibuprofen for acute neck or back pain with muscle spasm: a randomized trial.
Childers MK; Borenstein D; Brown RL; Gershon S; Hale ME; Petri M; Wan GJ; Laudadio C; Harrison DD
Curr Med Res Opin; 2005 Sep; 21(9):1485-93. PubMed ID: 16197668
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
